{"id":"NCT02242435","sponsor":"Ampio Pharmaceuticals. Inc.","briefTitle":"A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis","officialTitle":"A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Three Intra-articular Injections of Ampion™ (4 mL) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09","primaryCompletion":"2015-04","completion":"2015-05","firstPosted":"2014-09-17","resultsPosted":"2022-08-29","lastUpdate":"2022-09-15"},"enrollment":342,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis of the Knee"],"interventions":[{"type":"BIOLOGICAL","name":"4 mL injection of Ampion","otherNames":[]},{"type":"DRUG","name":"4 mL Injection of Placebo","otherNames":["Saline"]}],"arms":[{"label":"Ampion 4ml dose","type":"EXPERIMENTAL"},{"label":"Placebo Solution","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the efficacy of three intra-articular injections, given 2 weeks apart, of Ampion™ in Adults with pain due to osteoarthritis of the knee.","primaryOutcome":{"measure":"Change in Knee Pain","timeFrame":"Scored at Baseline and 20 Weeks","effectByArm":[{"arm":"Ampion 4 mL Injection","deltaMin":-0.96,"sd":null},{"arm":"Placebo 4 mL Injection","deltaMin":-1.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.26"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":172},"commonTop":["Arthralgia","Injection Site Pain","Upper Respiratory Tract Infection","Bronchitis","Contusion"]}}